Mettler-Toledo International (NYSE:MTD) Downgraded to “Underweight” at Barclays

Barclays downgraded shares of Mettler-Toledo International (NYSE:MTD) from an equal weight rating to an underweight rating in a research note published on Monday morning, Benzinga reports. They currently have $680.00 price objective on the medical instruments supplier’s stock.

Several other research firms have also weighed in on MTD. Bank of America lowered Propetro from a buy rating to a neutral rating in a research note on Tuesday, April 16th. Wolfe Research assumed coverage on Waters in a research note on Thursday, May 30th. They issued an underperform rating on the stock. ValuEngine lowered Zumiez from a hold rating to a sell rating in a research note on Monday, May 13th. Finally, Zacks Investment Research lowered Home Bancshares from a hold rating to a sell rating in a research note on Friday, June 7th. Two research analysts have rated the stock with a sell rating and six have assigned a hold rating to the stock. The stock presently has an average rating of Hold and a consensus target price of $673.83.

NYSE MTD opened at $818.13 on Monday. The firm has a market cap of $20.38 billion, a price-to-earnings ratio of 39.67, a P/E/G ratio of 2.64 and a beta of 1.33. Mettler-Toledo International has a 1-year low of $500.74 and a 1-year high of $873.51. The company has a quick ratio of 0.97, a current ratio of 1.37 and a debt-to-equity ratio of 1.80. The company has a 50-day moving average price of $810.81.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.06 by $0.04. The business had revenue of $679.50 million for the quarter, compared to analyst estimates of $673.55 million. Mettler-Toledo International had a return on equity of 95.67% and a net margin of 17.98%. The company’s revenue was up 2.8% compared to the same quarter last year. During the same period in the previous year, the company posted $3.74 EPS. On average, equities analysts expect that Mettler-Toledo International will post 22.7 earnings per share for the current fiscal year.

In related news, insider La Guerroniere Marc De sold 4,625 shares of the business’s stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $750.00, for a total transaction of $3,468,750.00. Following the transaction, the insider now directly owns 16,610 shares of the company’s stock, valued at approximately $12,457,500. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Shawn Vadala sold 700 shares of the business’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $721.00, for a total value of $504,700.00. Following the transaction, the chief financial officer now directly owns 5,450 shares in the company, valued at $3,929,450. The disclosure for this sale can be found here. Insiders have sold a total of 48,925 shares of company stock worth $35,650,928 over the last three months. 3.50% of the stock is currently owned by corporate insiders.

Institutional investors have recently added to or reduced their stakes in the stock. Permanens Capital L.P. acquired a new position in Mettler-Toledo International during the 1st quarter worth approximately $29,000. Executive Wealth Management LLC purchased a new stake in Mettler-Toledo International during the 4th quarter worth approximately $33,000. MARSHALL WACE ASIA Ltd purchased a new stake in Mettler-Toledo International during the 1st quarter worth approximately $44,000. Financial Gravity Wealth Inc. purchased a new stake in Mettler-Toledo International during the 1st quarter worth approximately $56,000. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in Mettler-Toledo International by 40.7% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 76 shares of the medical instruments supplier’s stock worth $55,000 after purchasing an additional 22 shares during the last quarter. 95.29% of the stock is currently owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.

Read More: Capital Gains

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.